UNLIMITED TURBO BULL - EVOTEC Stock

Certificat

FR18S

DE000SU63732

Market Closed - Euronext Paris 08:59:18 2024-04-24 EDT
0.82 EUR -79.60% Intraday chart for UNLIMITED TURBO BULL - EVOTEC
1 month-77.17%
3 months-83.92%

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying EVOTEC SE
IssuerLogo Issuer Société Générale Société Générale
FR18S
ISINDE000SU63732
Date issued 2024-01-18
Strike 10.17
Maturity Unlimited
Parity 1 : 1
Emission price 4.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.787
Lowest since issue 0.82

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
10.27 EUR
Average target price
21.99 EUR
Spread / Average Target
+114.12%
Consensus
  1. Stock Market
  2. Certificates
  3. FR18S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW